2Chen B,Jin B,Ziyadeh FN.Diabetic nephropathy and transforming growth factor-β:transforming our view of glomerulosclerosis and fibrosis build-up[J].Semin Nephrol,2003;23:532.
3Carlson PO,Berne C,Jansson L,et al.Angiotensin Ⅱ and the endocrine pancreas:effects on islet blood flow and insulin secretion in rats[J].Diabetologia,1998;41(2):127-9.
4Urata H,Bohem KD,Phlip A,et al.Cellular localization and regional distribution of an angiotensin Ⅱ forming chymase in the heart[J].J Clin Invest,1993;91 (4):1269-81.
5Azizi M,Chatellier G,Guyene T,et al.Additive effects of combined angiotensin converting enzyme inhibition and angiotensin Ⅱ antagonism on blood pressure and renin release in sodium depleted normotensives[J].Circulation,1995;92 (4):825-34.
6Russo D,Pisani A,Balletta MM,et al.Addictive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy[J].Am J Kid Dis,1999;33(5):851-6.
9American Diabetes Association. Standards of medical care in diabetes--2011 [ J ]. Diabetes Care ,2011,34 : S11-61.
10Patel A, MaeMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and mierovascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial ): a randomised controlled trial [ J ]. Lancet ,2007,370:829-840.
